Clinical and therapeutic implications of presymptomatic gene testing for familial amyloidotic polyneuropathy (FAP)

References

• (1994). Guidelines for the Molecular Genetics Predictive Test in Huntington s Disease. Neurology 44, 1533–1536
   PubMed Web of Science ®Google Scholar
• Sequeiros J and Coutinho P (1993). Epidemiology and Clinical Aspects of Machado-Joseph Disease, pp 139-153. (New York, NY: Raven Press)
   Google Scholar
• Sequeiros J (1996). O Teste Preditivo da Doença de Machado-Joseph. (Porto: UniGENe, IBMC)
   Google Scholar
• Silva MC, Coutinho P, Pinheiro D, Neves JM and Serrano P (1997). Hereditary ataxias and spastic paraplegias: methodological aspects of a prevalence study in Portugal. J Clin Epidemiol 50, 147–156
   PubMed Web of Science ®Google Scholar
• Saraiva MJM, Costa PP and Goodman DS (1985). Biochemical marker in familial amyloidotic polyneuropathy, Portuguese type. J Clin Invest 76, 171–2177
   Web of Science ®Google Scholar
• Saraiva MJM, Costa PP and Goodman DS (1986). Genetic expression of a transthyretin mutation in typical and late-onset Portuguese families with familial amyloidotic polyneuropathy. Neurology 36, 1413–1417
   PubMed Web of Science ®Google Scholar
• Saraiva MJM (2002). Sporadic cases of hereditary systemic amyloidosis (editorial). N Engl J Med 346, 1818–1819
   PubMed Web of Science ®Google Scholar
• Lachmann HJ, Chir B, Booth DR, Booth SE, Bybee A, Gilbertson JA, Gillmore JD, Pepys MB and Hawkins PN (2002). Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med 346, 1786–1791
   PubMed Web of Science ®Google Scholar
• Almeida MR, Sakaki Y, Costa PP and Saraiva MJM (1990). Prenatal diagnosis of Met 30 associated FAP by PCR. In Costa PP, Freitas AF and Saraiva MJM (eds). Familial Amyloidotic Polyneuropathy and Other Transthyretin related Disorders, pp 237-240. (Porto: Arquivas de Medicina)
   Google Scholar
• Carvalho F, Sousa M, Fernandes S, Silva J, Saraiva MJ and Barros A (2001). Preimplantation genetic diagnosis for familial amyloidotic polyneuropathy (FAP). Prenat Diagn 21, 1093–1099
   PubMed Web of Science ®Google Scholar
• Holmgren G, Steen L, Ekstedt J, Groth C and Ericzon BG (1991). Biochemical effects of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP Met 30). Clin Genet 40, 242–246
   PubMed Web of Science ®Google Scholar
• Ericzon BG, Holmgren G and Suhr OB (1999). New structural information and update on liver transplantation in transthyretin-associated amyloidosis. The 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders and the 3rd International Workshop on Liver Transplantation in Familial Amyloidotic Polyneuropathy, Umea, Sweden. Amyloid: Int J Exp Clin Invest 7, 145–147
   Google Scholar
• Monteiro E, Perdigoto R and Furtado AL (1998). Liver transplantation for familial amyloidotic polyneuropathy. Hepato Gastroenterol 45, 1375–1380
   PubMedGoogle Scholar
• Ramos M, Sousa A and Coclho T (1993). Impact of the presymptomatic test on the reproductive behaviour of Portuguese young adults at risk of FAP; a preliminary study (abstr.) J Rheumatol 20, 196
   Google Scholar
• Coelho T, Sousa A, Louren o E and Ramalheira J (1994). A study of 159 Portuguese patients with familial amyloidotic polyneuropathy (FAP) whose parents were both unaffected. J Med Genet 31, 293–299
   PubMed Web of Science ®Google Scholar
• Pa l C (1996). Reac es esperadas aos resultados do teste preditivo — a experi ncia dos programas de Doen a de Huntington. In Sequeiros J (ed.) O Teste Preditivo da Doença de Machado—Joseph. pp. 79 (Porto: UniGENC, IBMC)
   Google Scholar
• Carvalho M, Concei o I, Bentes C and Sales Lu s ML (2002). Long-term quantitative evaluation of liver transplantation in familial amyloid polyneuropathy (Portuguese V30M). Amyloid: J Protein Folding Disord 9, 126–133
   PubMed Web of Science ®Google Scholar
• Adams D, Samuel D, Goulon-Goeau C, Nakazato M, Costa PM, Feray C, Plante V, Ducot B, lehai P, Lacroix C, Metral S, Bismuth H and Said G (2000). The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 123, 1495–504
   PubMed Web of Science ®Google Scholar
• Coimbra A and Andrade C (1971). Familial amyloidotic polyneuropathy: an electron miscroscope study of peripheral nerve in five cases. II. Nerve fibril changes. Brain 94, 207–212
   Google Scholar
• Sales Lu s ML (1978). Electroneurophysiological studies in familial amyloid polyneuropathy — Portuguese type. J Neurol Neurosurg Psyehatr 41, 847–850
   PubMed Web of Science ®Google Scholar
• Sousa MM, Cardoso I, Fernandes R, Guimares A and Saraiva MJ (2001). Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy — evidence for toxicity of nonfibrillar aggregates. Am J Pathol 159, 1993-2000
   PubMed Web of Science ®Google Scholar
• Pepys MB, Herbert J, Hutchinson WL, Tennent GA, Lachmann HJ, Gallimore JR, Lovat LB, Bartfai T, Alanine A, Hertel C, Hoffmanns T Jakob-Roetne R, Norcross RD, Kemp JA, Yamamura K, Suzuki M, Taylor GW, Murray S, Thompson D, Purvis A, Kolstoe S, Wood SP and Hawkins PN (2002). Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature 417, 254–259
   PubMed Web of Science ®Google Scholar